The new $85 million Biologics Support Center, designed for Genzyme Corp by ARC / Architectural Resources Cambridge, has received LEED Gold certification from the US Green Building Council.
The 186,000-square-foot, six-story medical office building
was completed in July 2011 at 68 New York Ave. in Framingham, MA as part of a growing master-planned corporate campus. Genzyme will be consolidating a number of departments and laboratories in the building, which offers offices and conference space, technical support space, manufacturing, R&D and lab space and a data center all in one central location.
Of a total possible 69 points, the Biologics Support Center received 44 points for meeting rigorous benchmarks in six core areas: sustainable sites, water efficiency, energy and atmosphere, materials and resources, indoor environmental quality, and innovation and design process. Improvements at the building reduced energy cost savings by 27.7%, water use by 43.4%, diverted almost 90% of on-site generated construction waste, and 26.4% of building materials were manufactured locally from recycled content.
Thornton Tomasetti | Fore Solutions served as the LEED consultant on the project.
"With a second LEED Gold facility at its Framingham campus, Genzyme is a corporate leader in pursuing environmentally friendly policies in the region," said ARC principal-in-charge Tom Loring, AIA. "We are delighted to be able to help Genzyme realize its goals to create highly developed bio-science facilities in an environmentally sustainable fashion."